These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 33432947

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling.
    Kuang JR, Zhang ZH, Leng WL, Lei XT, Liang ZW.
    Mol Cell Endocrinol; 2017 May 15; 447():106-115. PubMed ID: 28237722
    [Abstract] [Full Text] [Related]

  • 26. Dietary leucine affects glucose metabolism and lipogenesis involved in TOR/PI3K/Akt signaling pathway for juvenile blunt snout bream Megalobrama amblycephala.
    Liang H, Mokrani A, Chisomo-Kasiya H, Ji K, Ge X, Ren M, Liu B, Xi B, Sun A.
    Fish Physiol Biochem; 2019 Apr 15; 45(2):719-732. PubMed ID: 30632024
    [Abstract] [Full Text] [Related]

  • 27. Dapagliflozin improves insulin resistance and glucose intolerance in a novel transgenic rat model of chronic glucose overproduction and glucose toxicity.
    Joannides CN, Mangiafico SP, Waters MF, Lamont BJ, Andrikopoulos S.
    Diabetes Obes Metab; 2017 Aug 15; 19(8):1135-1146. PubMed ID: 28244693
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.
    Ye Y, Bajaj M, Yang HC, Perez-Polo JR, Birnbaum Y.
    Cardiovasc Drugs Ther; 2017 Apr 15; 31(2):119-132. PubMed ID: 28447181
    [Abstract] [Full Text] [Related]

  • 33. Mulberry anthocyanin extract ameliorates insulin resistance by regulating PI3K/AKT pathway in HepG2 cells and db/db mice.
    Yan F, Dai G, Zheng X.
    J Nutr Biochem; 2016 Oct 15; 36():68-80. PubMed ID: 27580020
    [Abstract] [Full Text] [Related]

  • 34. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice.
    Nerurkar PV, Nishioka A, Eck PO, Johns LM, Volper E, Nerurkar VR.
    Br J Nutr; 2012 Jul 15; 108(2):218-228. PubMed ID: 22011624
    [Abstract] [Full Text] [Related]

  • 35. Prostaglandin F2α Facilitates Hepatic Glucose Production Through CaMKIIγ/p38/FOXO1 Signaling Pathway in Fasting and Obesity.
    Wang Y, Yan S, Xiao B, Zuo S, Zhang Q, Chen G, Yu Y, Chen D, Liu Q, Liu Y, Shen Y, Yu Y.
    Diabetes; 2018 Sep 15; 67(9):1748-1760. PubMed ID: 29773555
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors.
    Alatrach M, Laichuthai N, Martinez R, Agyin C, Ali AM, Al-Jobori H, Lavynenko O, Adams J, Triplitt C, DeFronzo R, Cersosimo E, Abdul-Ghani M.
    Diabetes; 2020 Apr 15; 69(4):681-688. PubMed ID: 31915153
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.